Related Experiment Video
Updated: Jan 24, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Fulvestrant-induced toxic epidermal necrolysis
Macarena Morales-Conde1, Natividad López-Ibáñez1, Julio Calvete-Candenas2
1Department of Dermatology of the University Hospital Virgen Macarena, Seville, Spain.
This case report details a rare instance of toxic epidermal necrolysis (TEN) triggered by fulvestrant, a medication used for advanced breast cancer. Early recognition and discontinuation of fulvestrant are crucial for managing this severe adverse drug reaction.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Toxic epidermal necrolysis (TEN) is a severe, life-threatening mucocutaneous reaction characterized by extensive keratinocyte apoptosis.
- Fulvestrant is a selective estrogen receptor degrader used for hormone receptor-positive metastatic breast cancer in postmenopausal women.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
Clinical Applications of Epidermal Stem Cells
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Induced Pluripotent Stem Cells
Spontaneous and Induced Mutations

